Search

Your search keyword '"BCG vaccines -- Dosage and administration"' showing total 38 results
Start Over Descriptor "BCG vaccines -- Dosage and administration"
38 results on '"BCG vaccines -- Dosage and administration"'

1. Findings from Memorial Sloan-Kettering Cancer Center Update Understanding of Bladder Cancer (Response To 2 Induction Courses of Bacillus Calmette-guerin Therapy Among Patients With High-risk Non-muscle-invasive Bladder Cancer)

Subjects
Care and treatment, Prevention, Risk factors, Patient outcomes, Dosage and administration, Cancer recurrence -- Risk factors -- Prevention, BCG -- Dosage and administration, Bladder cancer -- Risk factors -- Care and treatment -- Patient outcomes, BCG vaccines -- Dosage and administration, Cancer -- Relapse
Abstract

2024 APR 27 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on Oncology - Bladder Cancer are presented in a new [...]

Published
2024

2. BCG-unresponsive NMIBC: Advancements are moving the needle

Subjects
Diagnosis, Care and treatment, Patient outcomes, Dosage and administration, BCG -- Dosage and administration, Bladder cancer -- Diagnosis -- Care and treatment, Immunotherapy -- Patient outcomes, BCG vaccines -- Dosage and administration
Abstract

In 2024, I predict we will finally move the needle in terms of progress in treatment of non-muscle-invasive bladder cancer (NMIBC). Before I highlight this remarkable progress, I was curious [...]

Published
2024

3. Findings from Radboud University Nijmegen Medical Center Has Provided New Data on Bladder Cancer (Quality of Life In Patients With High-grade Non-muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus ...)

Subjects
Diagnosis, Care and treatment, Dosage and administration, Health aspects, BCG -- Dosage and administration, Bladder cancer -- Diagnosis -- Care and treatment, Quality of life -- Health aspects, BCG vaccines -- Dosage and administration
Abstract

2023 NOV 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Oncology - Bladder Cancer are discussed in a new [...]

Published
2023

4. Emerging treatments for high-risk BCG-unresponsive NMIBC

Subjects
Drug therapy, Development and progression, Patient outcomes, Dosage and administration, BCG -- Dosage and administration, Bladder cancer -- Development and progression -- Drug therapy -- Patient outcomes, BCG vaccines -- Dosage and administration
Abstract

The Viewpoints program from Urology Times brings together expert panels for in-depth discussions of key clinical topics. In this discussion, recorded at the 2024 American Urological Association Annual Meeting in [...]

Published
2024

5. Study Findings on Bladder Cancer Described by a Researcher at Shahid Beheshti University of Medical Sciences (Evaluating the Effectiveness of Intravesical Instillation of BCG by Modified Maintenance Method in Patients With High-Risk Ta and T1 ...)

Subjects
Care and treatment, Prevention, Development and progression, Risk factors, Patient outcomes, Dosage and administration, Cancer recurrence -- Risk factors -- Prevention, BCG -- Dosage and administration, Bladder cancer -- Development and progression -- Care and treatment, Transurethral bladder resection -- Patient outcomes, BCG vaccines -- Dosage and administration, Cancer -- Relapse, Bladder -- Surgery
Abstract

2023 JUL 29 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on bladder cancer is now available. According to news [...]

Published
2023

6. University of Washington Researcher Focuses on Bladder Cancer (Phase I/II randomized clinical trial of in-clinic acupuncture prior to BCG in patients with high-risk non-muscle invasive bladder cancer)

Subjects
Diagnosis, Care and treatment, Usage, Methods, Dosage and administration, Clinical trials -- Methods, BCG -- Dosage and administration, Bladder cancer -- Diagnosis -- Care and treatment, Acupuncture -- Usage -- Methods, BCG vaccines -- Dosage and administration
Abstract

2023 JUN 24 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on bladder cancer is the subject of a new report. [...]

Published
2023

7. Research Data from Kitasato University School of Medicine Update Understanding of Bladder Cancer (Efficacy of Intravesical Instillation Therapy With Low-dose Tokyo-172 Bacillus Calmette-guerin To Prevent Recurrence of Non-muscle-invasive ...)

Subjects
Diagnosis, Drug therapy, Prevention, Risk factors, Dosage and administration, BCG -- Dosage and administration, Bladder cancer -- Diagnosis -- Drug therapy, Recurrence (Disease) -- Risk factors -- Prevention, BCG vaccines -- Dosage and administration, Diseases -- Relapse
Abstract

2023 MAR 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on Oncology - Bladder Cancer are presented in a new [...]

Published
2023

8. Report Summarizes Urothelial Cancer Study Findings from Ankara University (Role of Pd-1/pd-l1-mediated Tumour Immune Escape Mechanism and Microsatellite Instability In the Bcg Failure of High-grade Urothelial Carcinomas)

Subjects
Care and treatment, Prognosis, Dosage and administration, Health aspects, Microsatellite instability -- Health aspects, BCG -- Dosage and administration, Bladder cancer -- Care and treatment -- Prognosis, BCG vaccines -- Dosage and administration
Abstract

2023 FEB 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Oncology - Urothelial Cancer have been presented. According to [...]

Published
2023

9. New Bladder Cancer Study Findings Have Been Reported by Researchers at Shanghai Jiao Tong University (Peripheral tuberculin purified protein derivative specific T cell immunoreactivity dynamics in non-muscle invasive bladder cancer patients ...)

Subjects
Diagnosis, Care and treatment, Prevention, Risk factors, Patient outcomes, Dosage and administration, Cancer recurrence -- Risk factors -- Prevention, BCG -- Dosage and administration, Bladder cancer -- Diagnosis -- Care and treatment, Transurethral bladder resection -- Patient outcomes, BCG vaccines -- Dosage and administration, Cancer -- Relapse, Bladder -- Surgery
Abstract

2022 NOV 19 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in bladder cancer. According to news reporting from [...]

Published
2022

10. New Bladder Cancer Study Findings Reported from Beijing Hospital (Bacillus Calmette-Guerin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer)

Subjects
Prevention, Development and progression, Dosage and administration, BCG -- Dosage and administration, Bladder cancer -- Development and progression -- Prevention, Cancer research, Recurrence (Disease) -- Prevention, Oncology, Experimental, BCG vaccines -- Dosage and administration, Diseases -- Relapse, Cancer -- Research
Abstract

2022 MAR 26 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on bladder cancer is the subject of a new report. [...]

Published
2022

11. Decrease in the effectiveness of Bacille Calmette-Guerin vaccine against pulmonary tuberculosis: a consequence of increased immune suppression by microbial antioxidants, not overattenuation

Author

Kernodle, Douglas S.

Subjects
BCG -- Dosage and administration, BCG vaccines -- Dosage and administration, Pulmonary tuberculosis -- Risk factors, Pulmonary tuberculosis -- Prevention, Pulmonary tuberculosis -- Genetic aspects, Immunosuppression -- Genetic aspects, Mycobacteria -- Genetic aspects, Mycobacterium -- Genetic aspects, Health, Health care industry
Published
2010

12. Tuberculous meningitis in BCG vaccinated and unvaccinated children

Author

Kumar, R., Dwivedi, A., Kumar, P., and Kohli, N.

Subjects
BCG vaccines -- Dosage and administration, Tuberculous meningitis -- Care and treatment, Tuberculous meningitis -- Patient outcomes, Outcome and process assessment (Health Care) -- Research, Children -- Diseases, Children -- Care and treatment, Children -- Research, Health, Psychology and mental health
Published
2005

13. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country

Author

Young Ae Kang, Ho Il Yoon, Sung Koo Han, Young-Soo Shim, Jae-Joon Yim, Hye Won Lee, and BeLong Cho

Subjects
BCG vaccines -- Dosage and administration, Mycobacterium tuberculosis -- Risk factors, Mycobacterium tuberculosis -- Drug therapy, Tuberculin test
Abstract

The tuberculin skin test (TST) and the whole-blood interferon gamma (IFN-gamma) assay are compared in the diagnosis of latent tuberculosis (TB) infection according to the intensity of exposure. The results reveal that the IFN-gamma assay is a better indicator of the risk of Mycobacterium tuberculosis infection than TST in a BCG-vaccinated population.

Published
2005

16. BCG vaccination status may predict sputum conversion in patients with pulmonary tuberculosis: a new consideration for an old vaccine?

Author

Jeremiah, Kidola, PrayGod, George, Faurholt-Jepsen, Daniel, Range, Nyagosya, Andersen, Aase B., Grewal, Harleen M., and Friis, Henrik

Subjects
BCG -- Dosage and administration, BCG -- Research, BCG vaccines -- Dosage and administration, BCG vaccines -- Research, Pulmonary tuberculosis -- Care and treatment, Pulmonary tuberculosis -- Prognosis, Pulmonary tuberculosis -- Research, Health
Published
2010

17. The effect of high-dose vitamin A supplementation given with Bacille Calmette-Guerin vaccine at birth on infant rotavirus infection and diarrhea: a randomized prospective study from Guinea-Bissau

Author

Diness, Birgitte Rode, Christoffersen, Dorthe, Pedersen, Ulla Britt, Rodrigues, Amabelia, Fischer, Thea Kolsen, Andersen, Andreas, Whittle, Hilton, Yazdanbakhsh, Maria, Aaby, Peter, and Benn, Christine Stabell

Subjects
Vitamin A -- Dosage and administration, Vitamin A -- Research, Dietary supplements -- Dosage and administration, Dietary supplements -- Research, BCG -- Dosage and administration, BCG -- Research, BCG vaccines -- Dosage and administration, BCG vaccines -- Research, Rotavirus infections -- Prevention, Rotavirus infections -- Research, Health
Published
2010

18. Gemcitabine versus bacille Calmette-Guerin after initial bacille Calmette-Guerin failure in non-muscle-invasive bladder cancer: a multicenter prospective randomized trial

Author

Di Lorenzo, Giuseppe, Perdona, SIsto, Damiano, Rocco, Faiella, Adriana, Cantiello, Francesco, Pignata, Sandro, Ascierto, Paolo, Simeone, Ester, De Sio, Marco, and Autorino, Riccardo

Subjects
Gemcitabine -- Dosage and administration, Gemcitabine -- Research, BCG -- Dosage and administration, BCG -- Research, BCG vaccines -- Dosage and administration, BCG vaccines -- Research, Bladder cancer -- Care and treatment, Bladder cancer -- Patient outcomes, Bladder cancer -- Research, Health
Published
2010

19. Vaccination with Bacille-Calmette Guerin promotes mycobacterial control in guinea pig macrophages infected in vivo

Author

Ly, Lan H., Barhoumi, Rola, Cho, Sang H., Franzblau, Scott G., and McMurray, David N.

Subjects
BCG -- Dosage and administration, BCG -- Research, BCG vaccines -- Dosage and administration, BCG vaccines -- Research, Tuberculosis -- Development and progression, Tuberculosis -- Research, Animal models in research -- Usage, Macrophages -- Physiological aspects, Macrophages -- Research, Health
Published
2008

21. Studies from University College Dublin Have Provided New Information about Mycobacterium bovis (Protective Immunity Against Tuberculosis In a Free-living Badger Population Vaccinated Orally With Mycobacterium Bovis Bacille Calmette-guerin)

Subjects
Drug therapy, Diseases, Prevention, Dosage and administration, BCG -- Dosage and administration, Badgers -- Drug therapy -- Diseases, Tuberculosis -- Prevention, Wildlife diseases -- Prevention, Veterinary vaccines -- Dosage and administration, BCG vaccines -- Dosage and administration
Abstract

2021 SEP 7 (NewsRx) -- By a News Reporter-Staff News Editor at Life Science Weekly -- Current study results on Gram-Positive Bacteria - Mycobacterium bovis have been published. According to [...]

Published
2021

22. Effect of high-dose vitamin A supplementation on the immune response to Bacille Calmette-Guerin vaccine

Author

Diness, Birgitte R., Fisker, Ane B., Roth, Adam, Yazdanbakhsh, Maria, Sartono, Erliyani, Whittle, Hilton, Nante, Jose E., Lisse, Ida M., Ravn, Henrik, Rodrigues, Amabelia, Aaby, Peter, and Benn, Christine S.

Subjects
BCG -- Dosage and administration, BCG -- Research, BCG vaccines -- Dosage and administration, BCG vaccines -- Research, Dietary supplements -- Health aspects, Dietary supplements -- Research, Vitamin A -- Health aspects, Vitamin A -- Research, Food/cooking/nutrition, Health
Abstract

Background: Vitamin A supplementation (VAS) at birth has been associated with decreased mortality in Asia. Bacille Calmette-Guerin (BCG) vaccine is given at birth in tuberculosis-endemic countries. Previous studies suggest that VAS may influence the immune response to vaccines. Objective: Our objective was to examine whether VAS influences the immune response to simultaneously administered BCG vaccine. Design: Within a randomized trial of 50 000IU vitamin A or placebo given with BCG vaccine at birth in Guinea-Bissau, 2710 infants were examined for BCG scar formation and delayed-type hypersensitivity (DTH) to purified protein derivative of Mycobacterium tuberculosis (PPD) at 2 and 6 mo of age. The ex vivo cytokine response to PPD was measured in 607 infants. Results: At 2 mo of age, 39% (43% of the boys and 34% of the girls) responded to PPD. The prevalence ratio of a measurable PPD reaction for VAS compared with placebo recipients was 0.90 (95% CI: 0.80, 1.02) for all infants, 0.81 (95% CI: 0.69, 0.95) for boys, and 1.04 (95% CI: 0.86, 1.26) for girls. At 6 mo of age, 42% of the infants responded to PPD. No difference was observed between VAS and placebo recipients. The prevalence of BCG scar was not affected by VAS. The ex vivo interferon-[gamma] response to PPD was increased by VAS (means ratio: 1.40; 95% CI: 1.03, 1.91). Conclusions: VAS with BCG vaccination does not appear to interfere with the long-term immune response to BCG. However, VAS temporarily altered the DTH reaction to PPD in boys at 2 mo of age, suggesting sex differences in the immunologic response to VAS given with BCG. This trial was registered at www.clinicaltrials.gov as #NCT00168597. KEY WORDS Bacille Calmette-Guerin, BCG vaccination, vitamin A, PPD response, purified protein derivative of Mycobacterium tuberculosis response, randomized trial, sex-differential effects

Published
2007

23. Bladder cancer: current optimal intravesical treatment

Author

Lamm, Donald L., McGee, William R., and Hale, Kaye

Subjects
Bladder cancer -- Care and treatment, Bladder cancer -- Risk factors, BCG vaccines -- Dosage and administration, Chemotherapy -- Dosage and administration, Nursing specialties -- Practice, Cancer -- Chemotherapy, Cancer -- Dosage and administration, Cancer -- Relapse, Cancer -- Prevention, Health, Health care industry
Published
2005

25. Research in the Area of Mycobacterium bovis Reported from Texas Biomedical Research Institute (Local immune responses to tuberculin skin challenge in Mycobacterium bovis BCG-vaccinated baboons: a pilot study of younger and older animals)

Subjects
Physiological aspects, Dosage and administration, BCG -- Dosage and administration, Mycobacterium bovis -- Physiological aspects, Skin -- Physiological aspects, Immune response -- Physiological aspects, BCG vaccines -- Dosage and administration
Abstract

2021 APR 27 (NewsRx) -- By a News Reporter-Staff News Editor at Life Science Weekly -- Research findings on Mycobacterium bovis are discussed in a new report. According to news [...]

Published
2021

26. Assessment of bacille Calmette-Guerin vaccine reaction in HIV-exposed Thai infants

Author

Chokephaibulkit, Kulkanya, Chotpitayasunondh, Tawee, Vanprapar, Nirun, Waranawat, Naris, Mock, Philip A., McConnell, Michelle S., Jetswang, Bongkoch, Neeyapun, Kanchana, Tappero, Jordan W., and Culnane, Mary

Subjects
BCG -- Dosage and administration, BCG -- Demographic aspects, BCG -- Physiological aspects, BCG vaccines -- Dosage and administration, BCG vaccines -- Demographic aspects, BCG vaccines -- Physiological aspects, Infants -- Testing, HIV infection in children -- Complications and side effects, HIV infection in children -- Demographic aspects, Human immunogenetics -- Research, Health, Health care industry
Published
2007

28. BCG vaccination: 90-years on and still so much to learn

Author

Lalvani, Ajit and Sridhar, Saranya

Subjects
BCG -- History, BCG -- Dosage and administration, BCG vaccines -- History, BCG vaccines -- Dosage and administration, Tuberculosis -- Prevention, Mycobacterium tuberculosis -- Prevention, Health
Published
2010

31. Usefulness of BCG reactivation in incomplete Kawasaki disease: a case series

Author

Sinha, Rajiv, Balakumar, T., and Sinha, Sarmistha

Subjects
Kawasaki disease -- Case studies, Kawasaki disease -- Diagnosis, BCG -- Dosage and administration, BCG vaccines -- Dosage and administration, Health
Abstract

Table of Contents Abstract Introduction Case 1 Case 2 Case 3 Discussion References Abstract Incomplete Kawasaki disease continues to be a major dilemma. Early diagnosis and appropriate intervention is important [...]

Published
2007

32. Independent Nurse: TB vaccination

Subjects
Care and treatment, Dosage and administration, Training, BCG -- Dosage and administration, Tuberculosis -- Care and treatment, Nurses -- Training, BCG vaccines -- Dosage and administration
Abstract

Responsibility for BCG must pass to primary care, say specialist TB nurses. TB specialist nurses feel primary care nurses should take on the main responsibility for BCG tests now that [...]

Published
2005

33. Topical BCG use can tackle genital warts

Subjects
Drug therapy, Dosage and administration, BCG -- Dosage and administration, Genital warts -- Drug therapy, BCG vaccines -- Dosage and administration, Condyloma acuminatum -- Drug therapy
Abstract

Topically applied BCG is an effective treatment for genital warts, according to an Egyptian study. Researchers treated 50 patients from Cairo University Hospital who had untreated genital warts for at [...]

Published
2005

34. Reply to Munsiff

Author

Tat, David, Polenakovik, Hari, and Herchline, Thomas

Subjects
BCG vaccines -- Dosage and administration, Skin diseases -- Drug therapy, Tuberculin test, Health, Health care industry
Published
2005

35. Non-specific effects of vaccines: in context

Author

Fine, Paul and Elliman, David

Subjects
Measles vaccine -- Dosage and administration, DPT vaccine -- Complications and side effects, Immunization -- Safety and security measures, BCG -- Dosage and administration, BCG vaccines -- Dosage and administration
Published
2010

36. Drug may be a treatment option for BCG failures

Author

Charnow, Jody A.

Subjects
Care and treatment, Research, Genetic aspects, Dosage and administration, Health aspects, Cancer treatment -- Research, Bacterial cell walls -- Genetic aspects -- Health aspects, BCG -- Dosage and administration, Bladder cancer -- Care and treatment, BCG vaccines -- Dosage and administration, Cancer -- Care and treatment
Abstract

MYCOBACTERIAL cell wall DNA complex (MCC) may provide an alternative to cystectomy for patients with non-muscle invasive bladder cancer refractory to bacillus Calmette-Guerin (BCG) treatment, according to preliminary study findings. [...]

Published
2011

37. Th1/Th2 Response Depends on BCG Dosage

Subjects
Prevention, Dosage and administration, Vaccines -- Dosage and administration, Lung research, BCG -- Dosage and administration, Tuberculosis -- Prevention, BCG vaccines -- Dosage and administration
Abstract

The mycobacterial dose used for immunization against tuberculosis determines the nature of the Th1/Th2 response independent of administration route, according to a report from Canada. It is believed that cell-mediated [...]

Published
1998

38. Intravesical versus intravesical plus intradermal bacillus Calmette-Guerin: a prospective randomized study in patients with recurrent superficial bladder tumors

Author

Luftenegger, W., Ackermann, D.K., Futterlieb, A., Kraft, R., Minder, C.E., Nadelhaft, P., and Studer, U.E.

Subjects
Care and treatment, Dosage and administration, BCG -- Dosage and administration, Bladder cancer -- Care and treatment, BCG vaccines -- Dosage and administration
Abstract

According to the authors' abstract of an article published in Journal of Urology, 'PURPOSE: Intravesical instillation of bacillus Calmette-Guerin (BCG) induces various immunological reactions and decreases the recurrence rate of [...]

Published
1996

Catalog

Books, media, physical & digital resources
See catalog results